$0.87 +0.03 (3.57%) Hemispherx Biopharma Inc - NYSE Amex Equities

Dec. 9, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 0.87
Trade Time: Dec 09 04:00 PM Eastern Daylight Time
Change: +0.03 (3.57%)
Prev Close: 0.84
Open: 0.85
Bid: 0.85
Ask: 0.88
  1. Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion on Application for Orphan Designation by the European Medicines Agency for Alferon N Injection to Treat Patients With Middle East Respiratory Syndrome (MERS)

    Benzinga | Oct. 19, 2015 | 07:30AM EST
  2. Hemispherx Biopharma Receives the European Patent Office Grant of New Composition of Matter Patent Covering Ampligen(R) Formulations

    Benzinga | Sep. 28, 2015 | 07:31AM EST
  3. Hemispherx Biopharma Reports Low NK Cell Activity in Chronic Fatigue Syndrome (CFS) and Relationship to Disease Symptoms

    Benzinga | Sep. 15, 2015 | 07:34AM EST
  4. Hemispherx Biopharma Enters Into Direct Supply Agreement With Gulf Coast Regional Blood Center to Supply Leukocytes to Manufacture Alferon N Injection(R)

    Benzinga | Aug. 24, 2015 | 07:32AM EST
  5. Hemispherx Biopharma Extends Its Strategic Alliance With Armada Health Care for Alferon N Injection

    Benzinga | Aug. 17, 2015 | 07:31AM EST
  6. Hemispherx Biopharma Board Names Thomas Equels as New President

    Benzinga | Aug. 13, 2015 | 07:35AM EST
  7. Hemispherx Expands Its Collaboration With Emerge Health for the Commercialization of Alferon in Australia and New Zealand

    Benzinga | Aug. 11, 2015 | 07:32AM EST
  8. Hemispherx Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola

    Benzinga | Oct. 20, 2014 | 11:01AM EST
  9. Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear

    IBD | Oct. 9, 2014 | 13:38PM EST
  10. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga | Oct. 8, 2014 | 12:04PM EST
  11. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga | Oct. 6, 2014 | 13:08PM EST
  12. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD | Oct. 1, 2014 | 13:20PM EST
  13. UPDATE: Hemispherx Biopharma Formally Collaborates With the Swiss Department of Defense, Civil Protection and Sports to Study Alferon(R) Against Tamiflu Resistant Influenza Virus Strains

    Benzinga | May. 14, 2014 | 07:35AM EST
  14. Hemisphrex Announces Publication of Ampligen Safety Profile Across Diverse Animal Species

    Benzinga | Apr. 8, 2014 | 07:35AM EST
  15. Hemispherx Shares Jump 13+% Following Release of Summarized Phase 1/2 Data on Flu Combo

    Benzinga | Feb. 4, 2014 | 08:49AM EST
Trading Center